Upadacitinib and Pain in RA, PsA

• by Kathryn Wighton

• February 25, 2026

Lung Disease Complicates RA Care

Patients with chronic lung disease had numerically lower remission rates and substantially more serious adverse events in a 5-year Japanese registry study of late-onset rheumatoid arthritis.

• by Andrea Surnit

• May 8, 2026

• 4 min

A machine learning-based classification model for interstitial lung disease in rheumatoid arthritis

• by Mingyao Li, Qiaoli Wang, Junfeng He, Xia Wang, Yangyang Xu, Liwei Yang, Lin Feng

• May 14, 2026

FDA Expands Guselkumab Label in PsA

Phase 3b APEX findings support the addition of structural joint damage inhibition data to the prescribing information.

• by Kathryn Wighton

• May 29, 2026

• 2 min